Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intensive therapy for aggressive lymphoma

Javier Bolaños-Meade

    The New England Journal of Medicine
    |July 9, 2004
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 study.

    bioRxiv : the preprint server for biology·2026
    Same author

    Optimizing Haploidentical Donor Selection for Pediatric Hematopoietic Cell Transplant.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
    Same author

    Bone marrow transplantation for sickle cell disease using posttransplantation cyclophosphamide and 400 cGy TBI.

    Blood advances·2026
    Same author

    Personalized Desensitization for Donor-Specific Anti-HLA Antibodies in Allogeneic Blood or Marrow Transplantation.

    Transplantation and cellular therapy·2025
    Same author

    Long-Term Follow-Up of the Baltimore Experience with Hematopoietic Cell Transplantation for Severe Aplastic Anemia Using Post-Transplantation Cyclophosphamide.

    Transplantation and cellular therapy·2025
    Same author

    Hematopoietic Cell Transplantation, Version 3.2025, NCCN Clinical Practice Guidelines In Oncology.

    Journal of the National Comprehensive Cancer Network : JNCCN·2025